0001799256-20-000001.txt : 20200109 0001799256-20-000001.hdr.sgml : 20200109 20200109111340 ACCESSION NUMBER: 0001799256-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200109 DATE AS OF CHANGE: 20200109 EFFECTIVENESS DATE: 20200109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Metuchen Pharmaceuticals, LLC CENTRAL INDEX KEY: 0001799256 IRS NUMBER: 813546200 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-357536 FILM NUMBER: 20517401 BUSINESS ADDRESS: STREET 1: 200 US HIGHWAY 9 STREET 2: SUITE 500 CITY: MANALAPAN STATE: NJ ZIP: 07726 BUSINESS PHONE: 732-761-8284 MAIL ADDRESS: STREET 1: 200 US HIGHWAY 9 STREET 2: SUITE 500 CITY: MANALAPAN STATE: NJ ZIP: 07726 D 1 primary_doc.xml X0708 D LIVE 0001799256 Metuchen Pharmaceuticals, LLC 200 US HIGHWAY 9 SUITE 500 MANALAPAN NJ NEW JERSEY 07726 848-233-5568 DELAWARE None None Limited Liability Company true 2016 John D. Shulman 5301 Wisconsin Ave NW Suite 570 Washington DC DISTRICT OF COLUMBIA 20015 Executive Officer Director Greg Ford 200 US Highway 9 Suite 500 Manalapan NJ NEW JERSEY 07726 Executive Officer Keith Lavan 200 US Highway 9 Suite 500 Manalapan NJ NEW JERSEY 07726 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2019-09-16 false true true false 0 3500000 3132739 367261 false 30 0 0 0 false Metuchen Pharmaceuticals, LLC /s/ Keith Lavan Keith Lavan Chief Financial Officer 2020-01-09